Page last updated: 2024-11-08

isochorismic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

isochorismic acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID189062
CHEBI ID17582
SCHEMBL ID239532
MeSH IDM0150223

Synonyms (22)

Synonym
1,3-cyclohexadiene-1-carboxylic acid, 5-[(1-carboxyvinyl)oxy]-6-hydroxy-, trans-
CHEBI:17582
(5s,6s)-5-[(1-carboxyethenyl)oxy]-6-hydroxycyclohexa-1,3-diene-1-carboxylic acid
1,3-cyclohexadiene-1-carboxylic acid, 5-[(1-carboxyethenyl)oxy]-6-hydroxy-, (5s,6s)- (9ci)
1,3-cyclohexadiene-1-carboxylic acid, 5-[(1-carboxyvinyl)oxy]-6-hydroxy-, trans- (8ci)
1,3-cyclohexadiene-1-carboxylic acid, 5-[(1-carboxyethenyl)oxy]-6-hydroxy-, (5s,6s)-
iso-chorismic acid
1,3-cyclohexadiene-1-carboxylic acid, 5-[(1-carboxyethenyl)oxy]-6-hydroxy-, (5s-trans)-
1,3-cyclohexadiene-1-carboxylic acid, 5-((1-carboxyethenyl)oxy)-6-hydroxy-, trans-
1,3-cyclohexadiene-1-carboxylic acid, 5-[(1-carboxyvinyl)oxy]-6-hydroxy-, trans- isochorismic acid
5-((1-carboxyethenyl)oxy)-6-hydroxy-1,3-cyclohexadiene-1-carboxylic acid
ISOCHORISMATE ,
isochorismic acid
C00885
22642-82-6
1NF8
SCHEMBL239532
5-[(1-carboxyvinyl)oxy]-6-hydroxy-1,3-cyclohexadiene-1-carboxylic acid #
NTGWPRCCOQCMGE-YUMQZZPRSA-N
1,3-cyclohexadiene-1-carboxylic acid, 5-[(1-carboxyethenyl)oxy]-6-hydroxy-, trans-
Q3604533
(5s,6s)-5-(1-carboxyethenoxy)-6-hydroxycyclohexa-1,3-diene-1-carboxylic acid

Research Excerpts

Overview

Isochorismic acid is a precursor to a growing number of shikimate-derived metabolites.

ExcerptReferenceRelevance
"Isochorismic acid is a precursor to a growing number of shikimate-derived metabolites."( Biosynthesis of isochorismate in Klebsiella pneumoniae: origin of O-2.
Devor, KA; Jensen, RA; Mamer, O; Sauriol, F; Tiberio, R; Zamir, LO, 1991
)
1

Effects

ExcerptReferenceRelevance
"Isochorismic acid has also been postulated to be an intermediate of m-carboxyaromatic amino acids, implying another enzymatic Claisen rearrangement."( Biosynthesis of isochorismate in Klebsiella pneumoniae: origin of O-2.
Devor, KA; Jensen, RA; Mamer, O; Sauriol, F; Tiberio, R; Zamir, LO, 1991
)
1
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
5-[(1-carboxyethenyl)oxy]-6-hydroxycyclohexa-1,3-diene-1-carboxylic acid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
vitamin K1218
Salicylate biosynthesis116

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, phenazine biosynthesis protein phzDPseudomonas aeruginosaKd0.01500.01500.01500.0150AID977611
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2003Biochemistry, May-20, Volume: 42, Issue:19
Structure and mechanism of Pseudomonas aeruginosa PhzD, an isochorismatase from the phenazine biosynthetic pathway.
AID1811Experimentally measured binding affinity data derived from PDB2003Biochemistry, May-20, Volume: 42, Issue:19
Structure and mechanism of Pseudomonas aeruginosa PhzD, an isochorismatase from the phenazine biosynthetic pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (52)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (7.69)18.7374
1990's8 (15.38)18.2507
2000's16 (30.77)29.6817
2010's22 (42.31)24.3611
2020's2 (3.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.53 (24.57)
Research Supply Index3.97 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.92%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other51 (98.08%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]